Kyoto University · Medicine
Professor Yukinori Matsuo's research lab specializes in radiation oncology, with a focus on advancing respiratory motion management in radiotherapy, stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma, and multimodal treatment strategies for pancreatic cancer. The lab investigates the clinical efficacy, safety, and long-term outcomes of advanced radiotherapy techniques, particularly in challenging cases where surgery or ablation are not viable. It also emphasizes the psychological well-being of radiation oncologists, addressing burnout and mental health in radiation oncology professionals. The lab integrates clinical research with quality improvement initiatives to optimize patient care and professional sustainability.
Figures are computed from collected data and may differ slightly.
Respiratory motion management (RMM) systems in external and stereotactic radiotherapies have been developed in the past two decades. Japanese medical service fee regulations introduced reimbursement for RMM from April 2012. Based on thorough discussions among the four academic societies concerned, these Guidelines have been developed to enable staff (radiation oncologists, radiological technologists, medical physicists, radiotherapy quality managers, radiation oncology nurses, and others) to app
Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been recognized as an alternative therapy for patients for whom standard modalities such as surgery (resection or transplantation) or ablation are deemed unsuitable. SBRT has the potential to improve the prognosis of HCC, as it can be used as an adjunct to other treatment modalities. The assessment of post-SBRT images of the treated
Treatment with gemcitabine combined with radiation therapy according to the present schedule is well tolerated and can provide prolonged survival in patients with localized, unresectable pancreatic cancer.
This study aimed to evaluate the self-reported prevalence of burnout and psychological morbidity among radiation oncologists members of the Kyoto Radiation Oncology Study Group (KROSG) and to identify factors contributing to burnout. We mailed an anonymous survey to 125 radiation oncologists members of the KROSG. The survey included; the demographic data, the Maslach Burnout Inventory - Human Services Survey (MBI-HSS) and the 12-item General Health Questionnaire (GHQ-12). There were 87 responses
Open papers in the app to read, cite, and organize with AI.
